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Anaemia is not a risk factor for progression
of acute kidney injury: a retrospective
analysis
Jonah Powell-Tuck1, Siobhan Crichton2, Mario Raimundo3, Luigi Camporota4, Duncan Wyncoll4
and Marlies Ostermann4*
Abstract
Background: In hospitalised patients, anaemia increases the risk of developing acute kidney injury (AKI). Our aim
was to determine whether anaemia also has an impact on the risk of progression from early AKI to more severe
AKI in critically ill patients.
Methods: We retrospectively analysed the data of patients admitted to the adult intensive care unit between 2007
and 2009 who had AKI I as per the AKI Network classification, and who had undergone haemodynamic monitoring
within 12 h of AKI I. We collected baseline characteristics, severity of illness, haemoglobin (Hb), and haemodynamic
parameters in the first 12 h of AKI I and differentiated between patients who progressed to AKI III and those who
did not. Univariate and multivariate logistic regression analyses were used to identify risk factors for progression.
Associations between Hb, arterial oxygen saturation and cardiac index were explored by receiver operating
characteristic curve analysis.
Results: Two hundred and ten patients (median age 70 years, 68 % male) underwent haemodynamic monitoring
within 12 h of AKI I; 85 (41.5 %) progressed to AKI III. The proportion of patients with underlying cardiac disease
was significantly higher among progressors versus non-progressors (58 % vs 34 %, respectively; p = 0.001). On the
first day of AKI I, progressors had a significantly higher Sequential Organ Failure Assessment score (9 vs 8; p < 0.001),
lower cardiac index (median 2.6 vs 3.3 L/min/m2; p < 0.001), higher arterial lactate (2 vs 1.6 mmol/L; p < 0.001),
higher central venous pressure (16 vs 13; p = 0.02), lower mean arterial blood pressure (median 71 vs 74 mmHg;
p = 0.01) and significantly higher requirement for cardiovascular and respiratory support, but there was no difference in
Hb concentration (median 96 g/L in both groups). Multivariable regression analysis showed that heart disease, need for
mechanical ventilation, arterial lactate, Sequential Organ Failure Assessment score, central venous pressure and cardiac
index on first day of AKI I were independently associated with progression to AKI III. There was no significant difference
in the risk of progression between patients with Hb≤ or >80 g/L, and≤ or >100 g/L on day of AKI I.
Conclusions: In critically ill patients with AKI stage 1, anaemia was not associated with an increased risk of progression
to more severe AKI.
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Background
Acute kidney injury (AKI) is a common complication of
critical illness, affecting more than 50 % of patients admit-
ted to intensive care units (ICUs) [1, 2]. There is a clear as-
sociation between severity of AKI and risk of short and
long-term complications, including death and development
of chronic kidney disease [3, 4]. Management of AKI is
supportive with focus on correction of volume depletion,
haemodynamic optimisation and avoidance of further
nephrotoxic insults. It is advised that management is
tailored to AKI stage, including early use of haemodynamic
monitoring [5], with the aims to reverse the injurious
process within the kidneys, to induce renal recovery and to
prevent progression to severe AKI.
We recently reported that a lower mean arterial pressure
(MAP), reduced systemic oxygen delivery and increased
fluid administration were independently associated with a
higher risk of progression from AKI stage I to AKI stage
III [6, 7]. However, it is unknown whether anaemia is also
a risk factor. This is an important question for several
reasons, since:
1. Anaemia is very common during critical illness and
blood transfusions are often withheld until
haemoglobin (Hb) is reduced to <70–80 g/L based
on large randomised controlled trials which showed
no survival benefit in patients with a higher Hb [8–10].
2. Hb is a key contributor to oxygen delivery.
3. Anaemia is a risk factor for the development of AKI
in hospitalised patients [11], after major surgery
[12–17] and following cardiac procedures [18, 19].
4. In patients undergoing cardiopulmonary bypass
surgery, haemodilution to a haematocrit of <24 % is
associated with an increased risk of postoperative
AKI [20].
5. In patients with chronic kidney disease (CKD),
correction of anaemia has been shown to slow the
progression of renal failure [21, 22].
6. In patients undergoing cardiac surgery, a single-dose
erythropoietin (EPO) administered before surgery
resulted in significant reduction in postoperative
AKI [23, 24].
The aim of this study was to determine whether an-
aemia has an impact on the risk of progression from early
AKI to more severe AKI during critical illness. We
hypothesised that critically ill patients with AKI and a low
Hb had a reduced chance of renal recovery compared to
AKI patients with a higher Hb.
Methods
We retrospectively reviewed an electronic database
(CareVue, Philips) containing data from all patients admit-
ted to Guy’s & St Thomas’ NHS Trust ICU between July
2007 and June 2009, and identified those with AKI stage I
as per serum creatinine criteria of the AKI Network
(AKIN) classification [25] in whom advanced haemo-
dynamic monitoring had been initiated for clinical reasons
within 12 h of the patient meeting the criteria for AKI
stage I. Renal transplant patients, re-admissions and pa-
tients who left the ICU within 24 h of diagnosis of AKI
I or developed AKI stage III within 12 h of diagnosis of
AKI I were excluded. The outcome of interest was pro-
gression to AKI stage III as defined by the AKIN classifi-
cation, i.e. rise of serum creatinine greater than threefold
from baseline or to ≥354 μmol/L with an acute rise of
≥44 μmol/L, or requirement for renal replacement therapy
(RRT) [25]. The methods have been described in more
detail elsewhere [6, 7].
Data collection
We recorded demographics, comorbidities, diagnosis,
Acute Physiology and Chronic Health Evaluation (APA-
CHE) II score and Sequential Organ Failure Assessment
(SOFA) score on admission to ICU and first available
cardiac index, contemporaneous arterial oxygen satur-
ation (SaO2), Hb, arterial lactate, central venous pressure
(CVP), MAP and urine output during the first 12 h
period after diagnosis of AKI I. We also recorded SOFA
score, 24-h urine output, cumulative fluid balance, need
for mechanical ventilation and cardiovascular support,
and presence of sepsis (as per current consensus criteria
[26]) on day of AKI I. Systemic oxygen delivery index
(DO2I) was calculated as DO2I = 1.34 × Hb × SaO2 ×
cardiac index.
Statistical analysis
Categorical variables were summarised as frequency
(percentage). SOFA scores were summarised as mean
and standard deviation (SD) and all other continuous
variables, which were not normally distributed, summarised
as median and interquartile range (IQR). Characteristics
were compared between patients who did and did not
progress using Chi-square, Fisher’s exact, Mann-Whitney
or t-tests, as appropriate.
Associations between components of the DO2I (Hb,
SaO2 and cardiac index) were explored using receiver
operating characteristic (ROC) curves. The area under
the curve (AUC) was used to compare the ability of the
three parameters to predict which patients progressed.
To determine which components of DO2I (i.e. Hb, SaO2
and cardiac index) were most strongly associated with
progression, multivariable logistic regression models were
used. In addition to the three parameters, any factors
which were found to be significant in univariate analyses
(mechanical ventilation, coronary artery disease (CAD)/
congestive cardiac failure (CCF), lactate, SOFA score on
day of AKI I, CVP and mean MAP in the 12-h period after
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diagnosis of AKI, urine output) were also included in the
model. In additional analyses, sepsis on day of AKI I was
added to the model and tests for interactions between sep-
sis and CAD/CCF and Hb, SaO2 and cardiac index were
performed to determine whether there were differences in
risk of progression in patients with CAD/CCF or sepsis.
The sensitivity and specificity associated with cut-off
points of Hb above and below 80 and 100 g/L were also
calculated. The differences in odds of progression for pa-
tients in the two groups were compared using logistic
regression models.
Ethics
The study had institutional approval by the Clinical
Governance Department in the hospital. As per Govern-
ance Arrangements for Research Ethics Committees
published by the UK Health Departments, formal review
by a Research Ethics Committee and need for individual
informed consent was not required since the research
was limited to secondary use of information previously
collected in the course of normal care and the patients
were not identifiable to the research team carrying out
the research [27].
Results
Of 2118 patients admitted to the ICU in the 2-year
period, 790 (37 %) had AKI stage I; 69 patients had ex-
clusion criteria and a further 511 patients were excluded
because they did not have haemodynamic monitoring
performed within the first 12 h of AKI I. The remaining
210 patients were included in the analysis (Table 1). The
median number of days between ICU admission and
AKI I was 1 (IQR 0–22).
Of 85 patients (41 %) who progressed to AKI III, 78
(92 %) received RRT. The mean duration between AKI I
and AKI III was 2.6 days (SD 3.4); the median duration was
2 days (IQR 1–2). Five patients with AKI I died before their
renal function recovered or progressed. The remaining 120
patients with AKI I recovered renal function.
Risk factors for progression to AKI stage III
Patients with AKI I who progressed to AKI III were
sicker on the day of AKI I as evidenced by a higher
SOFA score, higher arterial lactate level, lower MAP and
greater need for respiratory and cardiovascular support
(Table 2). There was no difference in the Hb concen-
tration of those who progressed to AKI III and those who
did not progress. Multivariable regression analysis showed
that underlying heart disease (CAD and/or CCF), need for
mechanical ventilation, arterial lactate, SOFA score and
CVP on day of AKI I were independent risk factors
for progression from AKI I to AKI III (Table 3). A higher
cardiac index was independently associated with a re-
duced risk.
Impact of anaemia
Figure 1 shows the ROC curves summarising the associ-
ation between Hb, SaO2, cardiac index and progression
to AKI III. Only cardiac index appeared to differentiate
between progressors and non-progressors. There was no
particular cut-off for Hb for progression. When choosing
80 g/L and 100 g/L as clinically meaningful cut-offs,
there was no significant difference in the risk of progres-
sion to AKI stage III between patients with Hb <80 g/L
on day of AKI I and those with a higher Hb or patients with
a Hb below or above 100 g/L (Table 4). There was also no
difference in the impact of Hb levels on progression in pa-
tients with or without underlying heart disease (CAD and/
or CCF) and between patients with or without sepsis.
Discussion
We previously demonstrated that a higher systemic
DO2I was independently associated with a reduced risk
of progression from AKI stage I to AKI stage III. In this
study we analysed the components of DO2I individually
and found that haemoglobin concentration was not in-
dependently associated with AKI progression. Instead,
the need for mechanical ventilation, the presence of
underlying cardiac disease, raised lactate, higher SOFA
Table 1 Baseline characteristics of patients with AKI I
Parameter Total (n = 210)
Age, median (IQR) 70 (57–77)
Male gender, n (%) 142 (68)
Comorbidities
CAD/CCF, n (%) 92 (44)
Chronic hypertension, n (%) 81 (39)
Diabetes mellitus, n (%) 40 (19)
Malignancy, n (%) 28 (13)
COPD, n (%) 27 (13)
CKD, n (%) 25 (12)
Neurological disease, n (%) 23 (11)
Chronic liver disease, n (%) 12 (6)
Admission diagnosis
Post-surgery, n (%) 72 (34)
Cardiac, n (%) 54 (26)
Sepsis, n (%) 38 (18)
Respiratory, n (%) 34 (16)
Other, n (%) 12 (6)
Severity of illness on admission to ICU
APACHE II score, median (IQR) 18 (14–22)
SOFA score, mean (SD) 7.1 (2.8)
AKI acute kidney injury, APACHE Acute Physiology and Chronic Health
Evaluation, CAD coronary artery disease, CCF congestive cardiac failure, CKD
chronic kidney disease, COPD chronic obstructive pulmonary disease, ICU
intensive care unit, IQR interquartile range, SD standard deviation, SOFA
Sequential Organ Failure Assessment
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score and a higher CVP were all independent risk factors
for progression; a higher cardiac index was independ-
ently associated with a reduced risk of progression.
The relationship between anaemia and AKI is not fully
understood. It is well known that AKI can contribute to
the development of anaemia as a result of reduced EPO
production, an increased risk of bleeding and reduced
red cell life span [28]. It has also been demonstrated that
anaemia is a risk factor for the development of AKI in
patients undergoing major surgery leading to increased
mortality [12, 14, 15]. However, it is not always clear
whether the presence of anaemia is simply a reflection
of co-morbid disease that increases the risk of AKI or a
direct contributor to AKI, for instance as a result of
anaemia-induced hypoxia in the renal cortex. The kid-
ney, particularly the proximal tubule, is known to be
very susceptible to ischaemic injury [29]. Using an ani-
mal model, Darby et al. showed a sustained reduction in
renal cortical and medullary oxygenation in rats which
were subjected to 1 h of normothermic cardiopulmonary
bypass with target Hb concentrations of 65 g/L [30].
Table 2 Comparison of AKI progressors and non-progressors
Parameters All (n = 210)* Did not progress to AKI III (n = 120) Progressed to AKI III (n = 85) p value
Age, median (IQR) 70.5 (57–77) 70 (54–76) 71 (60–78) 0.13
Male gender, n (%) 138 (67.3) 79 (65.8) 59 (69.4) 0.59
CAD/CCF, n (%) 92 (44) 41 (34.2) 49 (57.7) 0.001
Severity of illness on admission to ICU
SOFA score, mean (SD) 7.1 (2.8) 6.9 (2.7) 7.5 (2.9) 0.14
APACHE II score, median (IQR) 18 (14–22) 17 (13–21) 18 (15–22) 0.09
Parameters on day of AKI I
SOFA score, mean (SD) 8.7 (2.7) 8.0 (2.5) 9.6 (2.8) <0.001
Presence of sepsis, n (%) 125 (60) 79 (66.4) 43 (50.6) 0.02
DO2I (ml/min/m
2), median (IQR) 362 (277–482) 405 (302–514) 325 (266–401) <0.001
SaO2 0.95 (0.94–0.96) 0.95 (0.94–0.96) 0.95 (0.94–0.96) 0.81
Hb (g/L), median (IQR) 96 (88–105) 96 (90–105) 96 (85–105) 0.64
Cardiac index (L/min/m2), median (IQR) 3.0 (2.3–3.9) 3.3 (2.5–4.2) 2.6 (2.1–3.3) <0.001
Arterial lactate (mmol/L), median (IQR) 1.8 (1.3–2.6) 1.6 (1.1–2.3) 2 (1.5–3) <0.001
CVP (cmH2O), median (IQR) 14 (10–18) 13 (10–17) 16 (11–19) 0.02
MAP (mmHg), median (IQR) 73 (69–78) 74 (70–79) 71 (68–77) 0.01
Vasopressor/inotrope therapy, n (%) 187 (8) 100 (83.3) 82 (96.5) 0.003
Mechanical ventilation, n (%) 191 (91) 103 (85.8) 84 (98.8) 0.001
Urine output (mL/h), median (IQR) 61 (38–94) 66 (46–104) 54 (32–79) 0.002
Cumulative fluid balance (ml), median (IQR) 2361 (952–3812) 2379 (935–4222) 2363 (974–3719) 0.995
Outcome
ICU mortality, % 32.4 11.7 57.6 <0.001
Hospital mortality, % 43.3 24.2 67.1 <0.001
*Including 5 patients who died before their renal function recovered or progressed
AKI acute kidney injury, APACHE Acute Physiology and Chronic Health Evaluation, CAD coronary artery disease, CCF congestive cardiac failure, CVP central venous
pressure, DO2I systemic oxygen delivery index, ICU intensive care unit, IQR interquartile range, Hb haemoglobin, MAP mean arterial pressure, SaO2 arterial oxygen
saturation, SD standard deviation, SOFA Sequential Organ Failure Assessment
Table 3 Multivariable logistic regression models for progression
Parameters on day of AKI I OR 95 % CI p value
Mechanical ventilation 22.12 2.40–205.52 0.006
CAD/CCF 3.17 1.55–6.49 0.002
Arterial lactate (mmol/L) 1.57 1.15–2.13 0.004
SOFA score 1.21 1.04–1.39 0.01
CVP (cmH2O) 1.07 1.01–1.14 0.02
Cardiac index (L/min/m2) 0.69 0.50–0.96 0.03
MAP (mmHg) during 12 h post-AKI I 0.97 0.92–1.02 0.18
Hb (g/L) 0.82 0.65–1.03 0.09
SaO2 0.97 0.79–1.20 0.79
AKI acute kidney injury, CAD coronary artery disease, CCF congestive cardiac
failure, CI confidence interval, CVP central venous pressure, Hb haemoglobin,
MAP mean arterial pressure, OR odds ratio, SaO2 arterial oxygen saturation,
SOFA Sequential Organ Failure Assessment
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Lastly, blood transfusions in patients with AKI receiving
RRT have not been shown to have an impact on 90-day
mortality or other patient-centred outcomes [31].
To the best of our knowledge, the question whether
anaemia affects the chances of renal recovery has only
been explored once before in a retrospective study of
211 hospitalised patients [32]. The authors defined AKI
by the following: 0.5 mg/dL increase in serum creatinine
if the baseline serum creatinine was ≤1.9 mg/dL; 1.0 mg/
dL increase for baseline serum creatinine 2.0–4.9 mg/dL;
1.5 mg/dL increase if baseline serum creatinine was
≥5.0 mg/dL. Renal recovery was defined by complete or
near complete return of the creatinine to baseline, 50 %
reduction in creatinine from the peak creatinine, or dis-
continuation of RRT. The study showed that neither
renal recovery nor survival differed among patients with
mild versus severe anaemia as measured by fall in Hb or
nadir Hb. Although we defined AKI differently, and fo-
cussed on progression from AKI stage I to AKI stage III
versus non-progression, our study reaches a similar con-
clusion. Using two separate haemoglobin cut-offs, we
found that the risk of progression was not increased in
patients with AKI I and Hb <80 or Hb <100 g/L. The
previously demonstrated association between DO2I and
AKI progression [6] was predominantly determined by
underlying cardiac index but not Hb or SaO2. Of note,
we previously also found that once AKI was established,
attempts to increase a low DO2I did not prevent pro-
gression to AKI III [6] and excessive fluid administration
resulting in fluid accumulation was associated with an
increased risk of progression [7].
Given the high prevalence of anaemia in critically ill
patients, restrictive transfusion strategies and the high
incidence of AKI in critically ill patients, these results
are important. Nevertheless, some unanswered questions
remain. Firstly, we retrospectively analysed the data of
critically ill patients with AKI only in those where
haemodynamic monitoring was considered to be re-
quired. Whether anaemia affects renal recovery in pa-
tients who are less sick is not clear. Second, we defined
AKI by the creatinine and RRT criteria of the AKIN clas-
sification only [25]. It is possible that the association be-
tween anaemia and progression to AKI III would have
been different if we had also used the urine criteria to
identify patients with AKI. Third, we were not able to
explore whether blood transfusion was a risk factor for
progression of AKI. A recent retrospective study in pa-
tients with moderate anaemia showed an increased
Fig. 1 Receiver operating characteristic curves for progression to AKI stage III. AUC area under the curve, Hb haemoglobin, SaO2 arterial oxygen saturation
Table 4 Impact of different haemoglobin cut-offs on day of AKI I on risk of progression to AKI III
Hb on day of AKI I n Progression to AKI III, n (%) Sensitivity Specificity OR* 95 % CI p value
>80 g/L 190 78 (41.0) 8.2 % 93.3 % 1
≤80 g/L 15 7 (46.7) 2.05 0.58–7.12 0.27
>100 g/L 134 55 (41.0) 64.7 % 34.2 % 1
≤100 g/L 71 30 (42.3) 1.40 0.70–2.83 0.35
*Adjusted for arterial oxygen saturation, cardiac index, mechanical ventilation, coronary artery disease/congestive cardiac failure, arterial lactate, Sequential Organ
Failure Assessment score, central venous pressure and mean arterial pressure
AKI acute kidney injury, CI confidence interval, Hb haemoglobin, OR odds ratio
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incidence of AKI in those who were transfused [33]. We
cannot exclude that the theoretical benefits of a higher
Hb were counteracted by adverse effects from blood
transfusions. Fourth, we did not determine the aetiology
of anaemia and explore whether it was acute or chronic.
Also, we did not correct Hb levels for fluid accumulation
but note that there was no difference in cumulative fluid
balance on the day of AKI I. Fifth, we acknowledge that
our results may contradict those studies which showed
less AKI in cardiac surgery patients who had received
EPO treatment preoperatively [23, 24]. However, it is
possible that these effects were not simply due to correc-
tion of Hb but also prevention of blood transfusion and
other EPO-related organ protective effects, including in-
hibition of apoptosis [34]. Finally, we analysed data from
2007 to 2009 which included relatively few patients with
Hb <80 g/L. The cohort may have been too small to de-
tect a potential association between severe anaemia and
AKI progression.
Conclusions
Our study shows that, whilst a low cardiac index on the
first day of AKI was associated with progression to more
severe AKI, anaemia was not. Unanswered questions re-
main and further investigation is warranted. Until such
time, clinicians should prioritise optimisation of cardiac
index to reduce the risk of progression of AKI, but there
is no evidence that a higher Hb confers protection.
Key messages
 In critically ill patients with acute kidney injury
(AKI) stage I, the mean haemoglobin on the first
day of AKI was 96 g/L.
 There was no difference in the haemoglobin
concentration of patients who progressed to AKI III
and those who did not progress.
 Pre-existing heart disease, need for mechanical
ventilation, arterial lactate, SOFA score, central
venous pressure and cardiac index on the first day of
AKI stage I were independently associated with an
increased risk of progression from AKI stage I to
AKI stage III but haemoglobin was not.
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